Breaking News Instant updates and real-time market news.

OGI

Organigram

$7.02

0.46 (7.01%)

, AZRX

AzurRx BioPharma

$1.25

-0.23 (-15.54%)

18:55
07/08/19
07/08
18:55
07/08/19
18:55

Fly Intel: After Hours Movers

HIGHER: OrganiGram (OGI) up 6.9% after unveiling liquid, powdered cannabinoid product... AzurRX (AZRX) up 5.6% after initiating phase 2 clinical study for MS1819-SD. LOWER: New Mountain Finance (NMFC) down 2.9% after equity offering. Movers as of 18:45ET.

OGI

Organigram

$7.02

0.46 (7.01%)

AZRX

AzurRx BioPharma

$1.25

-0.23 (-15.54%)

NMFC

New Mountain Finance

$13.99

-0.03 (-0.21%)

  • 08

    Jul

  • 15

    Jul

  • 08

    Aug

  • 09

    Jul

OGI Organigram
$7.02

0.46 (7.01%)

AZRX AzurRx BioPharma
$1.25

-0.23 (-15.54%)

01/25/19
ROTH
01/25/19
INITIATION
Target $10.5
ROTH
Buy
AzurRx BioPharma initiated with a Buy at Roth Capital
Roth Capital analyst Jerry Isaacson initiated AzurRx BioPharma with a Buy rating and $10.50 price target. In a research note to investors, Isaacson says he assumes MS1819 to treat EPI in CF patients will be approved for the patient population in 2022, and says his model includes pricing starting at $18,000 per patient per year, in line with currently approved PERTs. MS1819 has numerous potential advantages over currently approved treatments, including reduced pill burden, and the fact that it is not derived from an animal source, he adds.
01/25/19
01/25/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. SS&C (SSNC) initiated with a Buy at Buckingham. 2. Capital Southwest (CSWC) initiated with a Neutral at B. Riley FBR. 3. Natural Gas Services (NGS) initiated with a Buy at Maxim. 4. Aptose Biosciences (APTO) initiated with an Outperform at Oppenheimer. 5. AzurRx BioPharma (AZRX) initiated with a Buy at Roth Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
02/14/19
MAXM
02/14/19
INITIATION
Target $5
MAXM
Buy
AzurRx BioPharma initiated with a Buy at Maxim
Maxim analyst Caroline Palomeque initiated AzurRx BioPharma with a Buy rating and a price target of $5. The analyst cites the company's prioritizing of MS1819-SD development in Cystic Fibrosis given the "relatively undifferentiated" Pancreatic Enzyme Replacement Therapy market, stating the drug would be the "first non-porcine product available for exocrine pancreatic insufficiency that lowers pill burden, reduces risk of allergic reaction and improves quality of life".
06/11/19
NATL
06/11/19
INITIATION
Target $9
NATL
Buy
AzurRx BioPharma initiated with a Buy at National Securities
National Securities analyst Jonathan Aschoff initiated AzurRx BioPharma with a Buy rating and $9 price target.
NMFC New Mountain Finance
$13.99

-0.03 (-0.21%)

TODAY'S FREE FLY STORIES

VIVE

Viveve

$0.41

-0.0155 (-3.68%)

07:16
07/23/19
07/23
07:16
07/23/19
07:16
Downgrade
Viveve rating change  »

Viveve downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RCI

Rogers Communications

$53.30

0.005 (0.01%)

07:16
07/23/19
07/23
07:16
07/23/19
07:16
Earnings
Rogers Communications reports Q2 adjusted EPS C$1.16 vs. C$1.07 last year »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

JBT

John Bean Technologies

$121.10

-0.995 (-0.81%)

07:16
07/23/19
07/23
07:16
07/23/19
07:16
Recommendations
John Bean Technologies analyst commentary  »

John Bean Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

  • 19

    Sep

IEX

IDEX Corp.

$164.74

0.31 (0.19%)

07:15
07/23/19
07/23
07:15
07/23/19
07:15
Recommendations
IDEX Corp. analyst commentary  »

IDEX Corp. price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

ROP

Roper Technologies

07:14
07/23/19
07/23
07:14
07/23/19
07:14
Recommendations
Roper Technologies analyst commentary  »

Roper Technologies price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

ACAD

Acadia

$25.97

0.28 (1.09%)

07:14
07/23/19
07/23
07:14
07/23/19
07:14
Recommendations
Acadia analyst commentary  »

Cantor sees failed trial,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

  • 20

    Aug

PTI

Proteostasis

$0.89

-0.0209 (-2.31%)

, GLPG

Galapagos

$187.55

4.1 (2.23%)

07:14
07/23/19
07/23
07:14
07/23/19
07:14
Hot Stocks
Proteostasis appoints Geoffrey Gilmartin as Chief Medical Officer »

Proteostasis Therapeutics…

PTI

Proteostasis

$0.89

-0.0209 (-2.31%)

GLPG

Galapagos

$187.55

4.1 (2.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 09

    Sep

RDHL

RedHill Biopharma

$8.35

0.24 (2.96%)

07:14
07/23/19
07/23
07:14
07/23/19
07:14
Earnings
RedHill Biopharma reports Q2 EPS (4c), consensus (35c) »

Reports Q2 revenue $1.6M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

XLNX

Xilinx

$124.24

1.52 (1.24%)

07:12
07/23/19
07/23
07:12
07/23/19
07:12
Initiation
Xilinx initiated  »

Xilinx initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 08

    Aug

FB

Facebook

$202.32

3.94 (1.99%)

07:12
07/23/19
07/23
07:12
07/23/19
07:12
Recommendations
Facebook analyst commentary  »

Facebook price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

CCBG

Capital City Bank

$24.70

0.11 (0.45%)

07:11
07/23/19
07/23
07:11
07/23/19
07:11
Earnings
Capital City Bank reports Q2 EPS 44c, consensus 42c »

"I am very…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$207.21

4.59 (2.27%)

07:10
07/23/19
07/23
07:10
07/23/19
07:10
Recommendations
Apple analyst commentary  »

KeyBanc sees little to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

  • 03

    Aug

MBIO

Mustang Bio

$3.09

-0.16 (-4.92%)

07:10
07/23/19
07/23
07:10
07/23/19
07:10
Hot Stocks
Mustang Bio treatment of acute myeloid leukemia granted FDA orphan status »

Mustang Bio's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UUGRY

United Utilities

$0.00

(0.00%)

07:09
07/23/19
07/23
07:09
07/23/19
07:09
Upgrade
United Utilities rating change  »

United Utilities upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LJPC

La Jolla

$8.54

-0.16 (-1.84%)

07:09
07/23/19
07/23
07:09
07/23/19
07:09
Hot Stocks
La Jolla treatment of malaria granted FDA orphan status »

La Jolla…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IPG

Interpublic Group

$22.78

-0.01 (-0.04%)

07:09
07/23/19
07/23
07:09
07/23/19
07:09
Hot Stocks
Interpublic Group remains on track to deliver 2%-3% organic growth »

Michael Roth,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 08

    Aug

UTX

United Technologies

$132.94

0.57 (0.43%)

07:08
07/23/19
07/23
07:08
07/23/19
07:08
Hot Stocks
Breaking Hot Stocks news story on United Technologies »

United Technologies up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

NGG

National Grid

$51.92

-0.02 (-0.04%)

07:08
07/23/19
07/23
07:08
07/23/19
07:08
Upgrade
National Grid rating change  »

National Grid upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

IRDM

Iridium

$24.15

0.43 (1.81%)

07:08
07/23/19
07/23
07:08
07/23/19
07:08
Hot Stocks
Iridium sees FY19 service revenue $440M »

Sees FY19 OEBITDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

IPG

Interpublic Group

$22.78

-0.01 (-0.04%)

07:08
07/23/19
07/23
07:08
07/23/19
07:08
Earnings
Interpublic Group reports Q2 adjusted EPS 46c, consensus 44c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 08

    Aug

REAL

RealReal

$24.84

0.69 (2.86%)

07:07
07/23/19
07/23
07:07
07/23/19
07:07
Initiation
RealReal initiated  »

RealReal initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Aug

PNR

Pentair

$37.59

0.21 (0.56%)

07:07
07/23/19
07/23
07:07
07/23/19
07:07
Earnings
Pentair sees Q3 adjusted EPS 54c-56c, consensus 55c »

The company expects third…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

ENGIY

Engie SA

$0.00

(0.00%)

07:07
07/23/19
07/23
07:07
07/23/19
07:07
Upgrade
Engie SA rating change  »

Engie SA upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IRDM

Iridium

$24.15

0.43 (1.81%)

07:06
07/23/19
07/23
07:06
07/23/19
07:06
Earnings
Iridium reports Q2 EPS (16c), consensus (19c) »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

PNR

Pentair

$37.59

0.21 (0.56%)

07:06
07/23/19
07/23
07:06
07/23/19
07:06
Earnings
Pentair updates FY19 adjusted EPS view to approx. $2.35 from $2.30-$2.35 »

Consensus is $2.31.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.